These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 10480303)

  • 1. Atypical X-linked agammaglobulinemia diagnosed in three adults.
    Hashimoto S; Miyawaki T; Futatani T; Kanegane H; Usui K; Nukiwa T; Namiuchi S; Matsushita M; Yamadori T; Suemura M; Kishimoto T; Tsukada S
    Intern Med; 1999 Sep; 38(9):722-5. PubMed ID: 10480303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent pneumonia with mild hypogammaglobulinemia diagnosed as X-linked agammaglobulinemia in adults.
    Usui K; Sasahara Y; Tazawa R; Hagiwara K; Tsukada S; Miyawaki T; Tsuchiya S; Nukiwa T
    Respir Res; 2001; 2(3):188-92. PubMed ID: 11686883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
    Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
    Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection.
    Futatani T; Miyawaki T; Tsukada S; Hashimoto S; Kunikata T; Arai S; Kurimoto M; Niida Y; Matsuoka H; Sakiyama Y; Iwata T; Tsuchiya S; Tatsuzawa O; Yoshizaki K; Kishimoto T
    Blood; 1998 Jan; 91(2):595-602. PubMed ID: 9427714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB; Lester T; Levinsky RJ; Kinnon C
    Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
    Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
    Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.
    Hashimoto S; Tsukada S; Matsushita M; Miyawaki T; Niida Y; Yachie A; Kobayashi S; Iwata T; Hayakawa H; Matsuoka H; Tsuge I; Yamadori T; Kunikata T; Arai S; Yoshizaki K; Taniguchi N; Kishimoto T
    Blood; 1996 Jul; 88(2):561-73. PubMed ID: 8695804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
    Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
    FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked agammaglobulinemia. A clinical and molecular analysis.
    Ochs HD; Smith CI
    Medicine (Baltimore); 1996 Nov; 75(6):287-99. PubMed ID: 8982147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
    Tao L; Boyd M; Gonye G; Malone B; Schwaber J
    Hum Mutat; 2000 Dec; 16(6):528-9. PubMed ID: 11102984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
    Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
    Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical spectrum of Bruton's agammaglobulinemia.
    Stewart DM; Lian L; Nelson DL
    Curr Allergy Asthma Rep; 2001 Nov; 1(6):558-65. PubMed ID: 11892085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and mutational analysis of X-linked agammaglobulinemia patients in Malaysia.
    Chear CT; Ismail IH; Chan KC; Noh LM; Kassim A; Latiff AHA; Gill SS; Ramly NH; Tan KK; Sundaraj C; Choo CM; Mohamed SAS; Baharin MF; Zamri AS; Yahya SNHS; Mohamad SB; Ripen AM
    Front Immunol; 2023; 14():1252765. PubMed ID: 37809070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and mutational characteristics of X-linked agammaglobulinemia and its carrier identified by flow cytometric assessment combined with genetic analysis.
    Kanegane H; Futatani T; Wang Y; Nomura K; Shinozaki K; Matsukura H; Kubota T; Tsukada S; Miyawaki T
    J Allergy Clin Immunol; 2001 Dec; 108(6):1012-20. PubMed ID: 11742281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia.
    Tani SM; Wang Y; Kanegane H; Futatani T; Pinto J; Vilela MM; Miyawaki T
    Hum Mutat; 2002 Sep; 20(3):235-6. PubMed ID: 12204007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of X-linked agammaglobulinemia diagnosed in adulthood.
    Stewart DM; Tian L; Nelson DL
    Clin Immunol; 2001 Apr; 99(1):94-9. PubMed ID: 11286545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry.
    Kanegane H; Tsukada S; Iwata T; Futatani T; Nomura K; Yamamoto J; Yoshida T; Agematsu K; Komiyama A; Miyawaki T
    Clin Exp Immunol; 2000 Jun; 120(3):512-7. PubMed ID: 10844531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.